FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Denies Metacel Ozobax Petition

[ Price : $8.95]

FDA denies a Metacel petition asking the agency to require flavoring tests for generic forms of the companys Ozobax.

ICH Model-Informed Drug Development Guide Out

[ Price : $8.95]

FDA publishes a draft International Council for Harmonization M15 guidance on model-informed drug development principles.

Sepsis Risk Assessment Test Gets Breakthrough Status

[ Price : $8.95]

FDA grants MeMed a breakthrough device designation for its MeMed Severity test, intended for use in determining risk assessments i...

Favorable Pirtobrutinib Data in Leukemia/Lymphoma: Lilly

[ Price : $8.95]

Confirmatory data evaluating Eli Lillys pirtobrutinib in adult patients with chronic lymphocytic leukemia or small lymphocytic lym...

FDA Clears 2 Pentax Endoscopes

[ Price : $8.95]

FDA clears Pentax Medical 510(k)s for new endoscope models for colonoscopy and upper GI use.

Guide on Standardized BIMO eSubmission Data

[ Price : $8.95]

Federal Register notice: FDA makes available a guidance entitled Standardized Format for Electronic Submission of NDA and BLA Cont...

Update on Baxter Recall of Hemodialysis Transfer Sets

[ Price : $8.95]

FDA updates a Baxter recall (device correction) of its MiniCap Extended Life PD Transfer Sets used in hemodialysis.

GSK Files for Nucala COPD Indication

[ Price : $8.95]

FDA accepts for review a supplemental NDA for Nucala (mepolizumab) and its use as an add-on maintenance treatment for patients wit...

Simplified Dosing for Cumberlands Acetadote OKd

[ Price : $8.95]

FDA approves a Cumberland Pharmaceuticals supplemental NDA for a simplified dosing regimen of its Acetadote (N-acetylcysteine for ...

Mixed Results on Keytruda Ovarian Cancer Study

[ Price : $8.95]

Merck says a Phase 3 KEYLYNK-001 trial evaluating Keytruda (pembrolizumab) plus chemotherapy followed by maintenance with Lynparza...